Neurology Program(AnHorn Medicines)

N/A

Report date: 2023/03/02 11:33:02
NME

Base Information

Drug NameNeurology Program(AnHorn Medicines)
Drug Alias NameN/A
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnHorn Medicines Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnHorn Medicines Co Ltd
Inactive CompaniesN/A
Active IndicationsNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A